PRDX1 and triple-negative breast carcinoma: In addition, a recent study concluded that DOX targets the antioxidant enzyme peroxiredoxin 1 (PRDX1) in triple-negative breast cancer cells, causing mitochondrial-oxidative damage and activating the intrinsic apoptosis pathway [43].